Hiroshi Ohtani

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida et al. · American Journal of Kidney Diseases · 2018 · 384 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer

Yasuhito Iseki, Masatsune Shibutani, Kiyoshi Maeda et al. · PLoS ONE · 2015 · 222 citations · Full text

Medicine, Oncology, Surgery +17

Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.

Nagara Tamaki, Hiroshi Ohtani, Keiji Yamashita et al. · PubMed · 1991 · 203 citations

Medicine, Cardiology, Nuclear Medicine +17

Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy

Hiroshi Ohtani, Hideki Wakui, Atsushi Komatsuda et al. · Nephrology Dialysis Transplantation · 2004 · 202 citations · Full text

Medicine, Nephrology, Pathology +10

IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis

Hirokazu Imai, Keiko Hamai, Atsushi Komatsuda et al. · Kidney International · 1997 · 191 citations

Medicine, Immunology, Nephrology +13